Missing data in trial-based cost-effectiveness analysis: The current state of play

Health Economics

Volumn 21, Issue 2, 2012, Pages 187-200

  Noble, Sian Marie ^a   Hollingworth, William ^a   Tilling, Kate ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cost effectiveness; Missing data; Randomised controlled trial

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BIAS (EPIDEMIOLOGY); COST-BENEFIT ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84855523282     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1693     Document Type: Article

References (21)

1. Briggs A, Clark T, Wolstenholme J, Clarke P. 2003. Missing.... presumed at random: cost-analysis of incomplete data. Health Economics 12: 377-392. (Pubitemid 36603549)
2. Brouwers EPM, Bruijne MC, Terluin B, Tiemens BG, Verhaak PFM. 2007. Cost-effectiveness of an activating intervention by social workers for patients with minor mental disorders on sick leave: a randomized controlled trial. The European Journal of Public Health 17: 214-220. (Pubitemid 46536732)
3. Burton A, Billingham LJ, Bryan S. 2007. Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. Clinical Trials 4: 154-161. (Pubitemid 46814850)
4. Byford S, Barrett B, Roberts C, Wilkinson P, Dubicka B, Kelvin RG, White L, Ford C, Breen S, Goodyer I. 2007. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression. British Journal of Psychiatry 191: 521-527. (Pubitemid 350273213)
5. Drummond MF, Becker DL, Hux M, Chancellor JVM, Duprat-Lomon I, Kubin R, Sagnier PP. 2003. An economic evaluation of sequential IV/po moxifloxacin therapy compared to IV/po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia. Chest 124: 526-535. (Pubitemid 37000129)
6. Edwards RT, Ceilleachair A, Bywater T, Hughes DA, Hutchings J. 2007. Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis. British Medical Journal 334: 682.
7. Evers S, Goossens M, de Vet H, van Tulder M, Ament A. 2005. Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria. International Journal of Technology Assessment in Health Care 21: 240-245. (Pubitemid 40656554)
8. Gilbert FJ, Grant AM, Gillan MGC, Vale LD, Campbell MK, Scott NW, Knight DJ, Wardlaw D. 2004. Low back pain: influence of early MR imaging or CT on treatment and outcome-multicenter randomized trial. Radiology 231: 343-351. (Pubitemid 38552887)
9. Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S. 2003. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. The British Journal of Psychiatry 183: 418-426. (Pubitemid 37357574)
10. Hollinghurst S, Redmond N, Costelloe C, Montgomery A, Fletcher M, Peters TJ, Hay AD. 2008a. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): economic evaluation of a randomised controlled trial. British Medical Journal 337: a1490.
11. Hollinghurst S, Sharp D, Ballard K, Barnett J, Beattie A, Evans M, Lewith G, Middleton K, Oxford F, Webley F, Little P. 2008b. Randomised controlled trial of Alexander technique lessons, exercise, and massage (ATEAM) for chronic and recurrent back pain: economic evaluation. British Medical Journal 337: a2656.
12. Johnston B, Wheeler L, Deuser J, Sousa KH. 2000. Outcomes of the Kaiser Permanente Tele-Home Health Research Project. Archives of Family Medicine 9: 40-45. (Pubitemid 30609723)
13. Kattan M, Stearns SC, Crain EF, Stout JW, Gergen PJ, Evans III R, Visness CM, Gruchalla RS, Morgan WJ, O'Connor GT, Mastin JP, Mitchell HE. 2005. Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma. Journal of Allergy and Clinical Immunology 116:1058-1063. (Pubitemid 41571788)
14. Little RJA, Rubin DB. 1987. Statistical Analysis With Missing Data. Wiley: New York.
15. McKenna C, Bojke L, Manca A, Adebajo A, Dickson J, Helliwell P, Morton V, Russell I, Torgerson D, Watson J. 2009. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis. Rheumatology 48: 558-563.
16. Moher D, Schulz KF, Altman DG. 2001. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357: 1191-1194. (Pubitemid 32378696)
17. Najafzadeh M, Marra CA, Sadatsafavi M, Aaron SD, Sullivan SD, Vandemheen KL, Jones PW, Fitzgerald JM. 2008. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. Thorax 63: 962-967.
18. National Institute for Health and Clinical Excellence (NICE). 2008. Guide to the Methods of Technology Appraisal. NICE: London.
19. Prinssen M, Buskens E, de Jong SE, Buth J, Mackaay AJ, Sambeek MR, Blankensteijn JD. 2007. Cost-effectiveness of conventional and endovascular repair of abdominal aortic aneurysms: results of a randomized trial. Journal of Vascular Surgery 46: 883-890.
20. Richardson G, Bloor K, Williams J, Russell I, Durai D, Cheung WY, Farrin A, Coulton S. 2009. Cost effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET). British Medical Journal 338: b270.
21. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. 2009. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. British Medical Journal 338: b2393.